Wird geladen...
The limits of oral therapy in pulmonary arterial hypertension management
Pulmonary arterial hypertension (PAH) is a devastating disease in which remodeling of the small pulmonary arteries leads to a progressive increase in pulmonary vascular resistance and right-sided heart failure. Over the past decade, new treatments for PAH, such as the use of ERAs, PDE-5 inhibitors a...
Gespeichert in:
| Veröffentlicht in: | Ther Clin Risk Manag |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4664513/ https://ncbi.nlm.nih.gov/pubmed/26648729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S49026 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|